These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13951123)

  • 1. [Preliminary observations on the therapy of angina pectoris with a new synthetic drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
    GUERRICCHIO G
    Minerva Cardioangiol; 1962 Nov; 10():766-71. PubMed ID: 13951123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental and clinical observations on the action of a new anti-angina drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine lactate or FPDFPA].
    MIGHELI B; ANSELMINO A; BERT G; ANFOSSI F; BIANCO A; PUPITA F
    Clin Ter; 1963 Mar; 24():530-42. PubMed ID: 13935671
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
    CESARI L
    Gazz Int Med Chir; 1962 Sep; 66():1994-2004. PubMed ID: 14019763
    [No Abstract]   [Full Text] [Related]  

  • 4. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
    DELLA PORTA P; LUCCHINI CR
    Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE ACTION OF N-(2-PHENYL-1-METHYLETHYL)-1,1-DIPHENYL-3-PROPYLAMINE ON ANGINA OF EFFORT].
    BRONSTEIN J; GALEANO JC; GOLDSTEIN B; PITTALUGA E; STEINMAN J
    Dia Med; 1963 Nov; 35():1950-1. PubMed ID: 14099805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of a preparation with antistenocardiac action, 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
    PRETOLANI E
    Gazz Int Med Chir; 1963 May; 67():1011-21. PubMed ID: 13986080
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of the action of 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in coronary insufficiency].
    PARON R; DA BROI GL
    Gazz Int Med Chir; 1962 Nov; 66():2496-521. PubMed ID: 13941569
    [No Abstract]   [Full Text] [Related]  

  • 8. [INVESTIGATION ON THE BEHAVIOR OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN) AGAINST THE ACTION OF NORADRENALINE].
    LINDNER E
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():475-84. PubMed ID: 14103284
    [No Abstract]   [Full Text] [Related]  

  • 9. [RESEARCH ON THE ANTIFIBRILLATORY ACTION OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN)].
    LINDNER E
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():485-500. PubMed ID: 14103285
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new synthetic substance in the therapy of angina pectoris, N-3'-phenyl-propyl-(2')-1,1-diphenyl-propyl-(3)-amine].
    BAROCELLI C
    Minerva Med; 1963 Apr; 54():1202-6. PubMed ID: 13969419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analogy of the effects of N-(1-methyl-2-phenylethyl)-1, 1-diphenyl-3-propylamine (Segontin) and reserpine on arterial pressure].
    SCHMITT H; SCHMITT H
    C R Seances Soc Biol Fil; 1962; 156():440-2. PubMed ID: 13908832
    [No Abstract]   [Full Text] [Related]  

  • 12. PRENYLAMINE ("SEGONTIN") IN PROPHYLAXIS OF ANGINA PECTORIS ATTACKS.
    STABLES DP; PROWSE CM; ELLIOTT GA
    S Afr Med J; 1964 Aug; 38():615-7. PubMed ID: 14194737
    [No Abstract]   [Full Text] [Related]  

  • 13. [3,3-Diphenyl-N-(alpha-methylphenethyl)-propylamine].
    URBINATI G
    Clin Ter; 1961 Aug; 21():178-86. PubMed ID: 13779294
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with a new substance (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in syndromes caused by coronary insufficiency].
    DE FELICE D; ROSSETTO L
    Gazz Int Med Chir; 1962 Sep; 66():1976-84. PubMed ID: 14025758
    [No Abstract]   [Full Text] [Related]  

  • 15. [CLINICAL TRIALS WITH PHENYL-DIPHENYL-PROPYL-AMINE IN CORONARY INSUFFICIENCY].
    TRILLA SANCHEZ E; BELLONCANEIRO JM; TORNER SOLER M
    Rev Esp Cardiol; 1963 Oct; 16():873-84. PubMed ID: 14117507
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of "tersavid", "marplan" and "segontin" in angina pectoris.
    PITT A; GOBLE AJ
    Med J Aust; 1963 Mar; 50(1)():466-8. PubMed ID: 13943842
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and electrocardiographic observations on the treatment of coronary insufficiency with phenyl-propyl-diphenyl-propylamine].
    ANSELMINO A; MILONE PA
    Minerva Med; 1963 Apr; 54():1206-12. PubMed ID: 14013283
    [No Abstract]   [Full Text] [Related]  

  • 18. [EFFECTIVENESS OF SEGONTIN IN ANGINA PECTORIS. EVALUATION OF O-2 DEFICIENCY AND EXERCISE LOAD].
    KIMURA E; USHIYAMA S; KOJIMA N; HAYAKAWA H; KANIE T
    Chiryo; 1964 Jan; 46():162-5. PubMed ID: 14110959
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical effects of a new anti-anginal agent, prenylamine ("Segontin").
    BAUMGARTEN A
    Med J Aust; 1962 Mar; 49(1)():429-31. PubMed ID: 13865947
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenylamine ("Segontin") in angina of effort.
    ANDERSON DE
    Med J Aust; 1963 Feb; 50(1)():149-50. PubMed ID: 14012827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.